<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02635958</url>
  </required_header>
  <id_info>
    <org_study_id>14-004659</org_study_id>
    <nct_id>NCT02635958</nct_id>
  </id_info>
  <brief_title>InBody Validation Study</brief_title>
  <acronym>InBody</acronym>
  <official_title>Validation of the InBody 770® for the Assessment of Body Composition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioSpace, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With, one in three Americans now having a body mass index (BMI) greater than 30, and the&#xD;
      fastest growing segment of the population having a BMI greater than 40, it is paramount to&#xD;
      conduct validation of approaches to measure body composition. Currently the dual-energy x-ray&#xD;
      absorptiometry (iDXA) is the gold standard for measuring the body composition. But it is&#xD;
      often difficult to perform since it is limited to specific height, weight and BMI's. InBody&#xD;
      is a tool which uses bio electric impedance to measure the body composition. This study will&#xD;
      compare both approaches. Validation is necessary as it is clinically quite pertinent to&#xD;
      accurately assess a patients' body fat percentage, fat free mass, and total body water and&#xD;
      changes that are occurring with nutritional support.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will use a stratified design. Eligible participants will be categorized with BMI&#xD;
      category to receive InBody followed by iDXA. A total of 176 participants will be placed in 1&#xD;
      of 4 arms (n = 44 per arm) based on their BMI: 1) 18.5-24.9; 2) 25-29.9; 3) 30-34.9; and 4) ≥&#xD;
      35. Within these arms, the 44 participants will participate in an InBody 770® body&#xD;
      composition measure as well as an iDXA body composition measure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">December 2019</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Body Composition Measures</measure>
    <time_frame>1 day</time_frame>
    <description>compare body composition measures between InBody and iDXA</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">176</enrollment>
  <condition>Validation Study</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>BMI 18.5 to 24.9</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>BMI 25 to 29.9</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>BMI 30 to 34.9</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <description>BMI ≥ 35</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with a BMI greater than 18.5 and weigh no more than 450 lbs.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between 18 and 65 years of age&#xD;
&#xD;
          -  Have a Body Mass Index ≥ 18.5 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Are not English speaking&#xD;
&#xD;
          -  Are younger than 18 years of age&#xD;
&#xD;
          -  Weigh more than 450 lbs&#xD;
&#xD;
          -  Taller than 6'6&quot; due to size constraints of the iDXA&#xD;
&#xD;
          -  Have a pacemaker, defibrillator, artificial lung, artificial heart,&#xD;
             electrocardiograph, or nerve simulator&#xD;
&#xD;
          -  People having radioactive iodine thyroid treatment.&#xD;
&#xD;
          -  People who have had a nuclear medicine study or a barium X-ray within the last 5 days.&#xD;
&#xD;
          -  People with large amounts of metal in their bodies.&#xD;
&#xD;
          -  People with arthritis of the spine recorded in the medical record.&#xD;
&#xD;
          -  Are pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan T Hurt, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>December 17, 2015</study_first_submitted>
  <study_first_submitted_qc>December 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2015</study_first_posted>
  <last_update_submitted>May 29, 2020</last_update_submitted>
  <last_update_submitted_qc>May 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Ryan T. Hurt, M.D., Ph.D.</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Body Mass Index</keyword>
  <keyword>BMI</keyword>
  <keyword>InBody</keyword>
  <keyword>iDXA</keyword>
  <keyword>validation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

